Management of deep endometriosis

J Nassif, Joseph Nassif, Pantelis Trompoukis, Trompoukis P, P Trompoukis, Barata S, S. Barata, A. Furtado, Furtado A, Gabriel B, Boris Gabriel, B Gabriel, A Wattiez, Arnaud Wattiez
Reproductive BioMedicine Online · 2010 · vol. 23(1) , pp. 25–33 · doi:10.1016/j.rbmo.2010.08.012 · PMID:21474383 · W2130679619
review OA: closed CC0 ⤵ 14 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This paper reviews current strategies for managing deep endometriosis, focusing on diagnosis, medical treatment, surgical interventions, and multidisciplinary approaches.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Deep endometriosis is still a challenging disease in terms of diagnosis and treatment. About 10-12% of women of reproductive age will have a form of endometriosis. This can affect pelvic as well as extra pelvic locations. Risk of malignant transformation has been studied over a long period of time. Medical and surgical treatments can be proposed to patients for endometriosis-associated pain depending on the severity of symptoms and location of the disease. Results and outcomes are different according to different publications. Understanding of the benefit of surgical treatment on fertility is increasing. The place of medical and surgical treatment in recurrent symptoms or disease is also of interest. Presented here is a review on the management of endometriosis in the light of recent data. Further investigations in many fields of endometriosis are still required.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Cell Transformation, Neoplastic Endometriosis Endometriosis Endometriosis Female Humans Infertility, Female Infertility, Female Infertility, Female Pregnancy Pregnancy Rate Randomized Controlled Trials as Topic Recurrence Treatment Outcome

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (52)

Cited by (14)

Source provenance

europepmc
last seen: 2026-09-21T06:08:07.822426+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:16:48.482574+00:00
License: CC0 · commercial use OK